Last reviewed · How we verify

Losartan Tablets

Istituto Auxologico Italiano · FDA-approved active Small molecule

Losartan blocks angiotensin II receptors on blood vessels and tissues, causing vasodilation and reducing blood pressure.

Losartan blocks angiotensin II receptors on blood vessels and tissues, causing vasodilation and reducing blood pressure. Used for Hypertension, Diabetic nephropathy in patients with type 2 diabetes, Heart failure with reduced ejection fraction.

At a glance

Generic nameLosartan Tablets
SponsorIstituto Auxologico Italiano
Drug classAngiotensin II receptor antagonist (ARB)
TargetAT1 receptor (angiotensin II type 1 receptor)
ModalitySmall molecule
Therapeutic areaCardiovascular
PhaseFDA-approved

Mechanism of action

Losartan is an angiotensin II receptor antagonist (ARB) that selectively blocks the AT1 receptor subtype. By preventing angiotensin II from binding to these receptors, it inhibits vasoconstriction and aldosterone secretion, leading to reduced peripheral vascular resistance and lower blood pressure. This mechanism also provides renal protection and reduces left ventricular hypertrophy.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results